Dr. Jay B. Wish
Jay B. Wish, MD is Medical Director of the Out-Patient Dialysis Unit at Indiana University Hospital, Chief Medical Officer for Dialysis at IU Health, and Professor of Clinical Medicine at Indiana University School of Medicine. He is past president of the National Forum of ESRD Networks and was the lead nephrology consultant to the Fistula First Breakthrough Initiative 2009-2012. He served on the Board of Directors of the Renal Physicians Association and the American Association of Kidney Patients and was the recipient of the latter’s Visionary Award in 2005. Dr. Wish is Vice Chairman of the Editorial Advisory Board for Nephrology News & Issues and is on the editorial boards of the Clinical Journal of the American Society of Nephrology and the Journal of the American Society of Nephrology. He has had numerous articles, editorials, reviews, and book chapters published, particularly in the areas of End-Stage Kidney Disease quality oversight/improvement, accountability, anemia management and vascular access.
-
MedCity Influencers, BioPharma, Opinion
Is the HIF-PHI class of next-generation kidney drugs doomed in the U.S.?
Kidney disease patients need access to innovative therapies to expand treatment choices and improve quality of life. The FDA should closely examine whether it is applying the appropriate benefit/risk assessment for new drugs intended for this population.
Promoted
Payer’s Place: Dawn Maroney
Dawn Maroney, President, Markets of Alignment Health and CEO of Alignment Health Plan, to discuss how they are using technology to provide better service and care to consumers.
Promoted
Applying Remote Patient Monitoring to Surgery Prep and Recovery, Oncology and Women’s Health
Join us to learn about the latest trends in remote monitoring and how to extend its benefits beyond chronic conditions to more patients – all while using fewer staff resources.
